🧠Study finds hemorrhagic transformation was associated with: ⏲️Onset-to-imaging time 🩸Presence of severe hypoperfusion ❌No interaction found between time & severe hypoperfusion Read more below👇 https://t.co/4zIUbqK9aa @UPensato @johanna_ospel @AshuPJadhav

📣New paper by @UPensato on the #leaky core in acute #stroke🩸🧠 @DCNSNeuro ▶️Severe hypoperfusion and time affect risk of hemorrhage ▶️BUT: No multiplicative interaction between the two ▶️their effects on hemorrhage risk are additive, not synergistic. https://t.co/YKV7ow3RC4

Presented at #ISC25: In the ESCAPE-MeVO trial involving patients with ischemic stroke due to medium-vessel occlusion, thrombectomy within 12 hours did not lead to a better functional outcome and lower mortality at 90 days than usual care. Full trial results:

#STROKE January #EditorPick: Nerinetide treatment is strongly associated with smaller final infarct volumes among patients not treated with alteplase — the reduction was greater among patients with poor prognostic factors. #AHAJournals https://t.co/XghE2vpSPV

New paper alert‼️ What clinical & imaging factors influence your thrombolysis decision making in LVO❓Check out results of ACT-WHEN2 international survey https://t.co/xrGFp56zYB @JSCVD2

Wondering what is the effect of TNK vs tPA on MeVOs? Check out our paper: https://t.co/m1AqmwaBDJ Similar safety, clinical outcomes and quality of life, however, TNK had better reperfusion rates than tPA @nishita_singh3 @Katha_MD @bijoymenon @AlmekhlafiMa @ActRrct #stroke

Ever wondered how your mRS 0-2 probability changes if you have a 5/ 10/ 20 ml infarct in the white matter? 🧐And what about the grey matter?🤔 #stroke #neurorad #neuroIR @draravindganesh @mayank_G0 Answer is here (or maybe more questions)⏩ https://t.co/Y3L7lwMHZc

Stroke Volume: The Primary Outcome Equalizer? In this #BloggingStroke post, Mitchell Silver discusses #Stroke article by Rinkel & @johanna_ospel et al. @mihill68 @TudorGJovin @mayank_G0 https://t.co/x3jOhrGtis

New from @JNIS_BMJ: https://t.co/10oQwQWY1d @CSC_Stroke @CanadianNeuroIR 🇨🇦CULVO study shows: 1) 1 in 5 decisions for late-window EVT will change with perfusion imaging vs without 2) Reliability of EVT decisions with or without perfusion imaging is not significantly different

Another really nice paper by @naterex2 👏👏@SVINJournal - this one's investigating infarct growth in the Escape-na1 trial: ➡️ https://t.co/P2EtveOsur @mayank_G0 @rosevmcd @NimaKashani @mihill68

CTP ghost infarct cores👻 in acute #stroke #EVT patients occur in 1 of 10 patients⚠️ Especially: in young patients ➡️with short #ischema duration ➡️with complete recanalization ➡️Post-EVT outcomes are good! https://t.co/qFH88eorLj @TheAJNR @mayank_G0 @NimaKashani

Our own @johanna_ospel talking dollars and sense about economic impact of stroke treatment and achieving TICI >2b (40% EVT dont). Better reperfusion leads to better quality of life and societal economic benefit, politicians to take note @brainconferenc1 @UCalgary @aspectsinstroke

A look back at last night's incredible drinks reception aboard the Cutty Sark! 📸Shout out to @MPP_Photography for the amazing photography #BartsBRAINConference

"You can use this with almost any device you would usually use for mechanical #Thrombectomy," claims David Fiorella, discussing the Millipede 088 superbore aspiration system and MARRS study at the #BartsBRAINConference @brainconferenc1 @Wayne_Perfuze

#ASPECTS #stroke training & certification📜 now available via @letsgetproof University (free, no sign-up required): ▶️ https://t.co/95uIsqg1mz ...check out those annotated DICOM example cases🧐 ▶️Want to get involved? Join the ASPECTS working group: https://t.co/alRXOMImFM

If you embark upon EVT but fail to achieve reperfusion, outcomes are significantly worse than medical management. Results #HERMES emphasize need for technical success & achieving high reperfusion rates https://t.co/rWBgkvbuHy #NateRex @Johanna_Ospel @RosevMcd @NimaKashani #Stroke

Plan for this year’s 2023 Toronto Interventional Neuroradiology Symposium & Karel Terbrugge Lectureship & Neurovascular Anatomy. SEPTEMBER 28-30, 2023 TORONTO, CA (HYBRID) https://t.co/G4xM0adHIz See 3-Day Packed Agenda @KBI_UHN @UofTMedIm @YoungNIR @WomenInNeuroIR @SickKidsNV

New online @JNIS_BMJ: ⬇️mRS 0-2 in incomplete reperfusion than near complete reperfusion ⬇️ mRS 0–2 MT-accessible occlusion than non-MT-accessible occlusion pattern. ⬆️ patients with MT-accessible occlusion had infarcts than with non-MT occlusion pattern (68% vs46%).

Dr. William Mack giving the CV Section Chair's Address. He emphasizes the strength of a multi-disciplinary team. #SNIS2023 @JNIS_BMJ @SNISinfo @fcalbuquerque51 @ducruetaf @DrAltschul @MattAmansMD @DanniDiestro @aurora_cruz @MattFusco_MD @cvsection

Team 🇨🇦 at #SNIS2023 having a grand time! @JNIS_BMJ @SNISinfo @CarmenPFarinas @PMuthusami @NimaKashani @DanniDiestro @SickKidsNV @SmhNeuroVasc